Cargando…
Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency
BACKGROUND: Based on the sample of obese children with relative growth hormone deficiency (GHD), the objective of our study was to determine the effects of rhGH treatment on cardiovascular risk factors, including body mass index (BMI), lipid levels and glucose metabolism index. METHODS: A total of 4...
Autores principales: | Liang, Shuang, Xue, Jiang, Li, Guimei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883519/ https://www.ncbi.nlm.nih.gov/pubmed/29615058 http://dx.doi.org/10.1186/s12944-018-0721-9 |
Ejemplares similares
-
Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study
por: Qiao, Yu, et al.
Publicado: (2019) -
An examination of the effects of different doses of recombinant human growth hormone on children with growth hormone deficiency
por: XUE, YING, et al.
Publicado: (2016) -
Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
por: Hou, Ling, et al.
Publicado: (2015) -
Effect of Vitamin D Combined with Recombinant Human Growth Hormone in Children with Growth Hormone Deficiency
por: Wang, Pingping, et al.
Publicado: (2022) -
Long-term Response to Recombinant Human Growth Hormone Therapy in Indian Children with Growth Hormone Deficiency
por: Gahlot, Monita, et al.
Publicado: (2019)